{"pmid":32398878,"title":"'Test, re-test, re-test': using inaccurate tests to greatly increase the accuracy of COVID-19 testing.","text":["'Test, re-test, re-test': using inaccurate tests to greatly increase the accuracy of COVID-19 testing.","Nat Med","Ramdas, Kamalini","Darzi, Ara","Jain, Sanjay","32398878"],"journal":"Nat Med","authors":["Ramdas, Kamalini","Darzi, Ara","Jain, Sanjay"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398878","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1038/s41591-020-0891-7","topics":["Diagnosis"],"weight":1,"_version_":1666714494794989568,"score":9.490897,"similar":[{"pmid":32389155,"title":"Utility of Re-testing for Diagnosis of SARS-CoV-2/COVID-19 in Hospitalized Patients: Impact of the Interval between Tests.","text":["Utility of Re-testing for Diagnosis of SARS-CoV-2/COVID-19 in Hospitalized Patients: Impact of the Interval between Tests.","Infect Control Hosp Epidemiol","Doll, Michelle","Pryor, Rachel","Mackey, Dorothy","Doern, Chris","Bryson, Alexandra","Bailey, Pamela","Cooper, Kaila","Godbout, Emily","Stevens, Michael P","Bearman, Gonzalo","32389155"],"journal":"Infect Control Hosp Epidemiol","authors":["Doll, Michelle","Pryor, Rachel","Mackey, Dorothy","Doern, Chris","Bryson, Alexandra","Bailey, Pamela","Cooper, Kaila","Godbout, Emily","Stevens, Michael P","Bearman, Gonzalo"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389155","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1017/ice.2020.224","topics":["Diagnosis"],"weight":1,"_version_":1666528579960176640,"score":69.00995},{"pmid":32472684,"title":"Seroconversion rate and diagnostic accuracy of serological tests for COVID-19.","text":["Seroconversion rate and diagnostic accuracy of serological tests for COVID-19.","Clin Infect Dis","Nagappa, Bharathnag","Marimuthu, Yamini","32472684"],"journal":"Clin Infect Dis","authors":["Nagappa, Bharathnag","Marimuthu, Yamini"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472684","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/cid/ciaa676","topics":["Diagnosis"],"weight":1,"_version_":1668255193307807744,"score":64.23811},{"pmid":32406424,"pmcid":"PMC7218348","title":"Covid-19: Why test? Who to test? How to test?","text":["Covid-19: Why test? Who to test? How to test?","Bull Acad Natl Med","32406424"],"journal":"Bull Acad Natl Med","date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406424","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.banm.2020.05.006","topics":["Diagnosis"],"weight":1,"_version_":1666802845479862273,"score":63.622402},{"pmid":32492212,"title":"Re-test Positive for SARS-CoV-2 RNA of \"Recovered\" Patients with COVID-19: Persistence, Sampling issues, or Re-infection?","text":["Re-test Positive for SARS-CoV-2 RNA of \"Recovered\" Patients with COVID-19: Persistence, Sampling issues, or Re-infection?","\"Re-test Positive\" for SARS-CoV-2 from \"recovered\" COVID-19 has been reported and raised several important questions for this novel coronavirus and COVID-19 disease. In this commentary, we discussed several questions: 1. Can SARS-CoV-2 re-infect the individuals who recovered from COVID-19? This question is also associated with other questions: whether or not SARS-CoV-2 infection induces protective reaction or neutralized antibody? Will SARS-CoV-2 vaccines work? 2. Why could some recovered COVID-19 patients be re-tested positive for SARS-CoV-2 RNA? 3. Are some recovered COVID-19 patients with re-testing positive for SARS-CoV-2 RNA infectious? 4. How should the COVID-19 patients with re-test positive for SARS-CoV-2 be managed? This article is protected by copyright. All rights reserved.","J Med Virol","Kang, Hanyujie","Wang, Yishan","Tong, Zhaohui","Liu, Xuefeng","32492212"],"abstract":["\"Re-test Positive\" for SARS-CoV-2 from \"recovered\" COVID-19 has been reported and raised several important questions for this novel coronavirus and COVID-19 disease. In this commentary, we discussed several questions: 1. Can SARS-CoV-2 re-infect the individuals who recovered from COVID-19? This question is also associated with other questions: whether or not SARS-CoV-2 infection induces protective reaction or neutralized antibody? Will SARS-CoV-2 vaccines work? 2. Why could some recovered COVID-19 patients be re-tested positive for SARS-CoV-2 RNA? 3. Are some recovered COVID-19 patients with re-testing positive for SARS-CoV-2 RNA infectious? 4. How should the COVID-19 patients with re-test positive for SARS-CoV-2 be managed? This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Kang, Hanyujie","Wang, Yishan","Tong, Zhaohui","Liu, Xuefeng"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492212","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26114","keywords":["coronavirus < virus classification","disease control","immunity/immunization < epidemiology","persistent infection < infection","sars coronavirus < virus classification"],"topics":["Diagnosis"],"weight":1,"_version_":1668892169229828096,"score":62.985497},{"pmid":32487681,"title":"SARS-CoV-2 serology: Test, test, test, but interpret with caution!","text":["SARS-CoV-2 serology: Test, test, test, but interpret with caution!","SARS-CoV-2 serological tests are a subject of intense interest and have the potential to significantly enhance the diagnostic capability of healthcare services in the current pandemic. However, as with all novel assays, significant validation is required to understand the clinical relevance of results.We present the first study to assess clinician interpretation of SARS-CoV-2 serology scenarios. We identify common key assumptions regarding patient infectivity and protection that are not currently supported by the SARS-CoV-2 evidence base. In this rapidly developing field, we therefore strongly recommend serological assay results are accompanied by clear interpretive support from laboratory and infectious diseases specialists.","Clin Med (Lond)","Bermingham, William H","Wilding, Thomas","Beck, Sarah","Huissoon, Aarnoud","32487681"],"abstract":["SARS-CoV-2 serological tests are a subject of intense interest and have the potential to significantly enhance the diagnostic capability of healthcare services in the current pandemic. However, as with all novel assays, significant validation is required to understand the clinical relevance of results.We present the first study to assess clinician interpretation of SARS-CoV-2 serology scenarios. We identify common key assumptions regarding patient infectivity and protection that are not currently supported by the SARS-CoV-2 evidence base. In this rapidly developing field, we therefore strongly recommend serological assay results are accompanied by clear interpretive support from laboratory and infectious diseases specialists."],"journal":"Clin Med (Lond)","authors":["Bermingham, William H","Wilding, Thomas","Beck, Sarah","Huissoon, Aarnoud"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487681","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7861/clinmed.2020-0170","keywords":["covid-19","sars-cov-2","interpretation of laboratory results","serology"],"topics":["Diagnosis"],"weight":1,"_version_":1668623433638871040,"score":57.89658}]}